Equity grants to INCYTE CORP (INCY) R&D head and holdings
Rhea-AI Filing Summary
INCYTE CORP’s President, Global Head of R&D Pablo J. Cagnoni received equity compensation awards on July 16, 2026, including 13,403 restricted stock units, 57,861 employee stock options at an exercise price of $116.65 per share, and 33,508 performance shares.
After these awards, he directly holds 231,332 common shares, including 183,200 shares issuable under unvested restricted stock units and earned performance stock units. The RSUs vest 25% annually over four years, options vest over four years, and performance shares may deliver up to 200% of a share based on three-year relative TSR.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 13,403 shares
Net Buy
3 txns
Insider
CAGNONI PABLO J
Role
President, Global Head of R&D
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Shares F3 | 33,508 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) F4 | 57,861 | $0.00 | -- |
| Grant/Award | Common Stock F1, F2 | 13,403 | $0.00 | -- |
Holdings After Transaction:
Performance Shares — 33,508 shares (Direct);
Employee Stock Option (right to buy) — 57,861 shares (Direct);
Common Stock — 231,332 shares (Direct)
Footnotes (4)
- F1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- F2. Including the July 16, 2026 grant, this includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- F3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
- F4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:
Key Figures
RSUs granted: 13,403 shares of Common Stock
Stock options granted: 57,861 options at $116.65 per share
Performance shares granted: 33,508 performance shares
+4 more
7 metrics
RSUs granted
13,403 shares of Common Stock
Restricted stock units granted to Pablo J. Cagnoni on July 16, 2026
Stock options granted
57,861 options at $116.65 per share
Employee stock options granted July 16, 2026; expire July 15, 2036
Performance shares granted
33,508 performance shares
Each performance share may deliver up to 200% of one share based on TSR
Common stock holdings after grants
231,332 shares
Direct common shares held by Pablo J. Cagnoni following July 16, 2026 awards
Unvested RSU and PSU underlying shares
183,200 shares
Shares issuable under previously reported unvested RSUs and earned performance stock units
Performance period start
January 1, 2026
Beginning of three-year performance period for TSR-based performance shares
Performance share vesting date
Third anniversary of grant date
Earned performance shares vest three years after July 16, 2026, subject to continued service
Key Terms
restricted stock units ("RSUs"), Performance Shares, total shareholder return ("TSR"), Performance Share Award Agreement, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents award of restricted stock units ("RSUs") that will vest 25% annually"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Employee Stock Option (right to buy) financial
"Employee Stock Option (right to buy) with an exercise price of $116.65"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did INCY grant to Pablo J. Cagnoni on July 16, 2026?
On July 16, 2026, Pablo J. Cagnoni received 13,403 restricted stock units, 57,861 employee stock options at $116.65 per share, and 33,508 performance shares, all relating to INCYTE CORP common stock as part of his executive compensation.
How do the RSUs granted to INCY’s Pablo Cagnoni vest?
The 13,403 restricted stock units vest 25% annually over four years. Each RSU may be settled only in INCYTE CORP common stock on a one-for-one basis, aligning Cagnoni’s compensation with long-term shareholder interests through multi-year vesting.
What are the terms of the stock options granted to INCY’s R&D president?
Cagnoni received 57,861 employee stock options with a per-share exercise price of $116.65, expiring on July 15, 2036. The first 25% vest after one year, with the remaining options vesting in monthly installments over the following three years.
Were Pablo Cagnoni’s INCY transactions reported under a Rule 10b5-1 plan?
The Rule 10b5-1 checkbox in the filing is not marked, and the footnotes do not reference any trading plan. The reported Form 4 transactions reflect equity grants rather than market purchases or sales under a pre-arranged Rule 10b5-1 plan.